CONCORD, Mass., April 27, 2022 /PRNewswire/ — Applied BioMath (www.appliedbiomath.com), the industry-leader in offering model-informed drug discovery and improvement (MID3) help to assist speed up and de-risk therapeutic analysis and improvement (R&D), at present introduced their participation at the Bio-IT World Conference and Expo occurring May 3-5, 2022 in Boston, MA.
Kas Subramanian, PhD, Executive Director of Modeling at Applied BioMath will current “Applications of Machine Learning in Preclinical Drug Discovery” inside the convention observe, AI for Drug Discovery and Development on Thursday, May 5, 2022 at 1:05 p.m. E.T. In this presentation, Dr. Subramanian will focus on how machine studying strategies can enhance effectivity in therapeutic R&D determination making. He will overview case research that show machine studying purposes to goal validation and lead optimization.
“Traditionally, therapeutic R&D requires experiments on many various targets, hits, leads, and candidates which might be based mostly on finest guesses,” stated John Burke, PhD, Co-founder, President and CEO of Applied BioMath. “By using synthetic intelligence and machine studying, challenge groups can computationally work with extra knowledge to higher inform experiments and develop higher therapeutics.”
To be taught extra about Applied BioMath’s presence at the Bio-IT World Conference and Expo, please go to www.appliedbiomath.com/BioIT22.
About Applied BioMath
Founded in 2013, Applied BioMath’s mission is to revolutionize drug invention. Applied BioMath applies biosimulation, together with quantitative methods pharmacology, PKPD, bioinformatics, machine studying, medical pharmacology, and software program options to present quantitative and predictive steering to biotechnology and pharmaceutical firms to assist speed up and de-risk therapeutic analysis and improvement. Their method employs proprietary algorithms and software program to help teams worldwide in decision-making from early analysis by way of all phases of medical trials. The Applied BioMath crew leverages their a long time of experience in biology, mathematical modeling and evaluation, high-performance computing, and {industry} expertise to assist teams higher perceive their therapeutic, its best-in-class parameters, aggressive benefits, sufferers, and one of the best path ahead into and in the clinic to enhance probability of medical idea and proof of mechanism, and lower late stage attrition charges. For extra details about Applied BioMath and its providers and software program, go to www.appliedbiomath.com.
Applied BioMath and the Applied BioMath emblem are registered logos of Applied BioMath, LLC.
Press Contact: Kristen Zannella ([email protected])
SOURCE Applied BioMath, LLC
https://www.prnewswire.com/news-releases/applied-biomath-llc-to-present-on-machine-learning-in-drug-discovery-at-bio-it-world-conference-and-expo-301534576.html
